ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

AGL Angle Plc

14.00
0.25 (1.82%)
28 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Angle Plc LSE:AGL London Ordinary Share GB0034330679 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.25 1.82% 14.00 13.50 14.50 14.625 13.75 13.75 1,091,536 16:29:12
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Business Services, Nec 2.19M -20.13M -0.0773 -1.81 36.48M
Angle Plc is listed in the Business Services sector of the London Stock Exchange with ticker AGL. The last closing price for Angle was 13.75p. Over the last year, Angle shares have traded in a share price range of 9.125p to 37.50p.

Angle currently has 260,580,547 shares in issue. The market capitalisation of Angle is £36.48 million. Angle has a price to earnings ratio (PE ratio) of -1.81.

Angle Share Discussion Threads

Showing 31251 to 31272 of 33925 messages
Chat Pages: Latest  1261  1260  1259  1258  1257  1256  1255  1254  1253  1252  1251  1250  Older
DateSubjectAuthorDiscuss
25/1/2024
14:27
Courtesy of WTP on SCLP board from The Specator 'Where are the smart investments under a Starmer government?' :-

'Finally, pharma, in which any advance that might improve NHS performance or relieve its pressure points must be worth a look. A safety-first approach would involve quoted specialist investment trusts such as Polar Capital Global, Biotech Growth Trust and International Biotechnology Trust – or even safer, a holding in AstraZeneca as a pillar of the sector. But for a little more excitement our man picks three smaller companies in the process of seeking US Federal Drug Administration approval for their products and with reasonable cash runways: Scancell in immunology; Destiny Pharma in infection prevention; and Angle in liquid biopsy technology. Shield Therapeutics, with an iron deficiency drug already FDA-approved, could be a fourth. A spread across those four, plus Cohort, is a bet the veteran investor has already made for himself; but as ever, he urges you to do your own research'

bermudashorts
25/1/2024
14:26
Yep NT at 17p or fill or kill 15000 max at 17p
dave4545
25/1/2024
14:25
Agree Dave certainly not seeing the blocks of selling witness over the past week.
No really volume on offer at 17p

john henry
25/1/2024
14:19
Could pop any minute
rb1947
25/1/2024
14:19
This albeit it at a much lower price is looking a lot better today, the panic bouts of selling have gone and now it seems to be turning so looks like bottom in around 16p earlier and now the fomo can begin with a hopefully landslide of lucky people who sold much higher all trying to get back in for next run up
dave4545
25/1/2024
14:13
Thanks Waterloo . Good response . I can't see how the fda could handle all the extra workload tbh . They take years to get things done as it is .
bones698
25/1/2024
13:49
Sells seemed to have dried up
rb1947
25/1/2024
13:15
waterloo,

Thanks very much for taking the time to find out and report back.

bermudashorts
25/1/2024
12:19
Post all news here waterloo

Anybody want any websites or links in the header just post them here. I do not like overdoing headers because I'm not a fan of scrolling down loads to get to the current posts.

dave4545
25/1/2024
11:40
Waterloo, many thanks for emailing AN and sharing his response. It is very helpful clarification.
radderssandy
25/1/2024
11:24
Not sure which board to post on: In response to the potential changes FDA are seeking re labs running unapproved tests.

Had a reply from AN, to paraphrase, he doubts it will get ratified but would cause a lot of problems for labs as they would need to get each test through FDA, so while it would cause issues in the industry, with FDA for Parsortix it could work in our favour

"we are in a stronger position as we have already got an FDA product clearance and this can be used as a platform for FDA extension of the label to specific uses for LDTs, so this will be a big advantage and much easier than starting from scratch which other tests will have to do."

waterloo01
25/1/2024
11:20
Had a reply from AN, to paraphrase, he doubts it will get ratified but would cause a lot of problems for labs as they would need to get each test through FDA, so while it would cause issues in the industry, with FDA for Parsortix it could work in our favour

"we are in a stronger position as we have already got an FDA product clearance and this can be used as a platform for FDA extension of the label to specific uses for LDTs, so this will be a big advantage and much easier than starting from scratch which other tests will have to do."

waterloo01
25/1/2024
10:24
Added another 100k via a 75k and a 25k too.

Thing is if you are a brave punter and buy weakness and they turn you can make a killing.

Lots of bombed out bio's, over in EVG a massive seller fund which has caused the price to tank has just sold the last of their holding and now all those that took the chance should get rewarded.

Plenty of bombed out stocks in that sector, of course the risk is placings for all you just never know but for me I cannot see stocks raising money when prices are close to all time lows, you wait for better times especially if you still have cash for another 6-18 months etc etc

dave4545
25/1/2024
10:20
I have watched agl too long to rush into anything I either get my price or I don't . I still hold plenty but it's just nice to be in profit for once and I'm sure many on here would like to be in that situation .
Plenty of time yet to see what happens . Perhaps if you stopped buying for a bit it might drop a bit more lol

bones698
25/1/2024
09:36
I know on the news it had closed 13-13.5p but opened 16-17p, got chased and even got sold off first thing before it did 100%+ in the afternoon and closed around 30p before touching 37p the next day.

And people are still squabbling over 1p here, just looks so far that there is more support now on dips and not the usual rush of selling when 1-2 sales appear which make it look like it's turning and then people waiting for 16p offer will miss out on 17p offer then say if it drops to 16.5p offer I'll buy then it goes to 17.5p offer and price runs away from them as fomo returns

dave4545
25/1/2024
09:32
John Henry. Bottom of the gap is 14p? Bid should go to that 90%chance?
flavio_monteiro
25/1/2024
09:19
Top of gap 15.5p MID ping to 15.75p Bid 15.5p

Time to start accumulating.

john henry
25/1/2024
08:55
A possible nibble?
boris cobaka
25/1/2024
08:53
Morning Anglers!

Sumfink fishy goin on 'ere.

boris cobaka
25/1/2024
08:52
We have another week or two before the GC so I'm happy to wait while.the idiots sell . Ofc news could change that but nice to be able to relax and sit tight for a change after a torrid 2023 . Should be due some more news soon hopefully

Can't believe some idiots are taking 15.8 p after the recent news and spike . Some very novice traders around . Not aimed at you Dave haha

bones698
25/1/2024
08:50
25k's at 16.4 and 16.425p are mine..

Back in a bit...

dave4545
25/1/2024
08:39
For once I want these sheep to start selling because I never got a top up around 16p, refused 16.84p on the jump up because as we know when one person sells there tends to be 5-10 that follow and that is slowly happening so backing off for now
dave4545
Chat Pages: Latest  1261  1260  1259  1258  1257  1256  1255  1254  1253  1252  1251  1250  Older

Your Recent History

Delayed Upgrade Clock